-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
-
-
-
-
-
-
-
Stifel on Xenon Pharmaceuticals (XENE): 'We continue to believe >$2B US peak sales in FOS is very realistic'
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) PT Raised to $100 at Jefferies
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE): "we see further room for upside"
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) PT Raised to $66 at Stifel
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Xenon Pharmaceuticals (XENE)
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) joins Russell 2000 and 3000
-
479,029 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


